Succinyl-CoA:3-oxoacid coenzyme A transferase (SCOT) deficiency: A rare and potentially fatal metabolic disease
Sarah C. Grünert(University Medical Center Freiburg), Jörn Oliver Sass(Boston Children's Hospital), Wyatt W. Yue(Energy Biosciences Institute), Corinne Gemperle-Britschgi(University Children's Hospital Zurich), Lisa Stübbe(Feuerwehr Dortmund), Sabrina MacKinnon(University of Oxford), Ute Spiekerkoetter(University Medical Center Freiburg), Allan M. Lund(Copenhagen University Hospital), Christina Pontes(Heidelberg University), Natalie Weinhold(Charité - Universitätsmedizin Berlin), Sylvia Roloff(Humboldt-Universität zu Berlin), Eissa Faqeih(King Fahd Medical City), Anke Schumann(University Medical Center Freiburg), Melanie Walter(The University of Sydney), Ali Alasmari(King Fahd Medical City), William R. Foster(University of Oxford), Raina Yamamoto(Feuerwehr Dortmund), Osama A. Obaid
Cited by 18
Related Papers
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
|Diabetologia|2010|313
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation
|Journal of Inherited Metabolic Disease|2015|248
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
|Orphanet Journal of Rare Diseases|2011|237